📈 Stocks 🌍 United States

Pivotal Research Initiates SpaceX Coverage With $220 Price Target

Pivotal Research sets a $220 target for SpaceX, betting that Starship's rapid reusability will unlock massive cost efficiencies and drive long-term growth despite significant dilution and lockup risks.

🕐 1 min read

1 assets impacted (Stocks). Net bias: 1 Bullish, 0 Bearish, 0 Neutral. Strongest signal: SPCX ↑ 7/10 (55% confidence).

📊 Affected Assets (1)

SPCX
Bullish 🤖 55%
📆 Mid-term 🌍 US · Explicit

Pivotal Research initiated coverage with a Buy rating and a $220 year-end 2027 price target, implying about 50% upside, though lockup expiry and binary Starship risks temper conviction.

🎯 Key Takeaways

  • Pivotal Research projects SpaceX revenue to grow from $46.6 billion in 2026 to $118.2 billion by 2027.
  • The investment thesis relies on Starship achieving 20 to 50 flights per vehicle to drastically reduce orbital delivery costs.
  • Investors face binary risks, with a bearish scenario valuation of $75 per share if reusability targets are missed.
  • The company faces ongoing share dilution concerns following a major lockup expiry on September 9.

📝 Executive Summary

Pivotal Research Group has initiated coverage on SpaceX (SPCX) with a Buy rating and a $220 price target, suggesting 50% upside by 2027. The firm's bullish thesis hinges entirely on the successful rapid reusability of the Starship vehicle, which could slash launch costs by 90% and transform the company's long-term economics.

❓ FAQ

What is the primary driver behind Pivotal Research's bullish outlook on SpaceX?

The firm's outlook is predicated on the Starship vehicle achieving rapid, inexpensive reusability, which would fundamentally lower launch costs and enable large-scale expansion in Starlink and AI infrastructure.

What are the main risks identified for SpaceX investors?

Key risks include the binary outcome of Starship's engineering milestones, significant capital requirements exceeding $1 trillion over the next decade, and potential share dilution from ongoing lockup expirations.